Description: Human longevity is one of the great success stories of the past century, and there is growing consensus that there are further gains to come. What will these future gains look like, where will they come from and how likely are they to happen. Furthermore, how do we as actuaries deal with the uncertainty when trying to predict future long-term mortality improvements more than 20 years into the future. This is one of the most important assumptions on the balance sheet that insurers and reinsurers make, so it is important to have a strong perspective on it. Our presentation will give attendees a view into some of the core components of how to assess long-term mortality improvements by looking at the cyclical nature across different countries of life expectancy. It will also deep dive into the different drivers of life expectancy over the past cycle driven largely by improved diagnosis and treatment of cardiovascular disease (CVD) and cessation of smoking, which ended in about 2010. It will then discuss how population mortality improvement has slowed and plateaued in many major countries.

Description: In memory of Harold Dershowitz.

Description: The frequent use and complexity of today's actuarial projection models have increased the importance of efficient models. Model optimization can reduce both cloud costs and overall end-to-end clock times. This, in turn, enables companies to do more with less, such as reducing close times, increasing controls, enhancing analysis, doing more complicated calculations, and/or improving employee workloads during the close. From design and data to execution and audit, join us to explore techniques that can be applied throughout the actuarial modeling process to optimize actuarial models for improved run-time, accuracy, and reliability. We will focus on techniques that don't rely on model compression.

Description: Summarizes the results of a follow-up survey of a panel of experts on COVID-19 to see how views on the disease’s impact on future U.S. mortality may have changed.

Description: Modifiable risk factors stand out today as significant contributors to diseases, and yet we as an industry haven't tackled this. Instead, we sit by almost passively as obesity, diabetes and hypertension rates continue to skyrocket. In fact, obesity and overweight is now over 70% of the US population and has turned into the forgotten pandemic. Globally, no country in the world has improved their obesity percentage rates during the past 15 years. Insurers are starting to explore health interventions which have the potential to reduce claims and change people's behavior.

Description: In Memory of Harold G. Ingraham Jr.

Description: This study was undertaken to ensure the ongoing adequacy of the modified 1985 CIDA table as specified in Valuation Manual Section VM-26 for single premium credit disability insurance. In addition, the shift in the distribution of sales by term between contracts issued in previous study periods to 2017 and 2021 was analyzed.

Description: What learnings and challenges did 2023 Long Duration Targeting Improvement (LDTI) adopters experience? What's ahead for 2025 adopters? And how do companies leverage LDTI to improve data and analytics and benefits operations? Join the session for a deep dive into what's next on the horizon.

Description: The SOA is seeking proposals to study how recent U.S. obesity trends—especially the use of anti-obesity medications—may impact future mortality across demographics for actuarial applications

Description: Impact of Family Structure on Aspects of Retirement